Author

Lotte Geerlofs

University Medical Center Utrecht

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

Elena PerenthaleriD· 1 shared Ewout J. N. GroeniD· 1 shared Fay‐Lynn AsselmaniD· 1 shared Gabriella VieroiD· 1 shared Harriet McHale-OweniD· 1 shared Ilaria SignoriaiD· 1 shared Jared W Green· 1 shared Joris V Kortooms· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Elena PerenthalerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts

Ilaria Signoria, Maria M Zwartkruis, Lotte Geerlofs, Elena Perenthaler, Kiterie M. E. Faller, Rachel James, Harriet McHale-Owen, Jared W Green, Joris V Kortooms, Sophie H. Snellen, Fay‐Lynn Asselman, Thomas Henry Gillingwater, Gabriella Viero, Renske I. Wadman, W. Ludo van der Pol, Ewout J. N. Groen

The paper analyzes responses to SMN2 splice-modifying treatments in SMA fibroblasts, finding variability in treatment efficacy based on patient-specific factors.

Molecular Therapy — Methods & Clinical Development · Nov 13, 2024Peer-reviewedMolecular Biology